Spinal Stenosis Clinical Trial
— PASSOfficial title:
Developing a Novel Physical Activity Intervention for Patients Following Lumbar Spine Surgery (PASS Trial)
NCT number | NCT04591249 |
Other study ID # | 201126 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | October 7, 2020 |
Est. completion date | December 1, 2021 |
Verified date | March 2022 |
Source | Vanderbilt University Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
There is a critical need to target physical activity during postoperative management to optimize long-term recovery after lumbar spine surgery. The overall objective of this study is to conduct a two-group randomized control trial (RCT) to examine the feasibility and acceptability of a physical activity telehealth intervention delivered by a physical therapist for improving disability, physical function, pain, and physical activity compared to usual care after spine surgery for a degenerative lumbar condition. The physical activity intervention will include wearable technology and remote physical therapist support to counsel patients on a realistic progression of physical activity (steps per day). The central hypothesis is that this 8-week physical activity intervention performed at two weeks after surgery will be feasible and acceptable. The results of our randomized trial will be used to support a large multi-site clinical trial to test the effectiveness and implementation of this intervention
Status | Completed |
Enrollment | 16 |
Est. completion date | December 1, 2021 |
Est. primary completion date | September 24, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Adults age 18 years or older, of both sexes and all races 2. Scheduled for surgical treatment of a lumbar degenerative condition (spinal stenosis, spondylosis with or without myelopathy, and degenerative spondylolisthesis) using laminectomy with or without arthrodesis (i.e., fusion) procedures. 3. Participants will be English speaking due to the feasibility of employing study personnel to deliver and assess the study intervention. Exclusion Criteria: 1. Patients having microsurgical techniques as the primary procedure, such as an isolated laminotomy or microdiscectomy will be excluded because individuals having these minimally invasive surgical techniques tend to have a less severe case of lumbar degeneration. 2. Patients having surgery for spinal deformity as the primary indication or surgery secondary to pseudarthrosis, trauma, infection, or tumor 3. Prior history of lumbar spine surgery 4. Presence of back and/or lower extremity pain < 3 month 5. History of neurological disorder, resulting in moderate to severe movement dysfunction 6. Unable to provide stable address and access to a telephone indicating the inability to participate in the intervention. |
Country | Name | City | State |
---|---|---|---|
United States | Vanderbilt University Medical Center | Nashville | Tennessee |
Lead Sponsor | Collaborator |
---|---|
Vanderbilt University Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Opioid Use | A single-item Patient-reported opioid use questionnaire (yes vs. no). | Preoperative, and at 2 weeks (baseline), 3-, and 6-months after spine surgery | |
Primary | Recruitment rate | Proportion of potential eligible participants successfully contacted who agreed to participate and randomized. | At 2 weeks after spine surgery | |
Primary | Adherence rate to study protocol at 3 months after spine surgery | Proportion of participants who will complete the assessment at 2 weeks and 3 months after spine surgery. | From 2 weeks to 3-months after spine surgery | |
Primary | Adherence rate to study protocol at 6 months after spine surgery | Proportion of participants who will complete the assessment at 2 weeks and 6 months after spine surgery. | From 2 weeks to 6-months after spine surgery | |
Primary | Adherence to physical activity intervention | Number of weekly step goals completed by participant, which will be examined via Fitabase.
In addition, number of weekly Zoom calls completed with the physical therapist will be recorded |
From 2-weeks to 3-months after spine surgery | |
Primary | Number of adverse events | During the intervention phase, the study physical therapist will document adverse events related to walking to assess safety. | From 2-weeks to 3-months after spine surgery | |
Secondary | Oswestry Disability Index | A 10-item questionnaire will be used to measure condition-specific disability that assesses the impact of lumbar spinal disorders on activities of daily living. Each item is measured from 0 to 5, representing low and high disability, respectively. Total score ranges from 0 to 50. | Preoperative, and at 2 weeks (baseline), 3-, and 6-months after spine surgery | |
Secondary | PROMIS Physical Function | PROMIS Physical Function 4-item short form will be used to measure physical function. Each item is measured from 1 to 5, representing low to high physical function, respectively. Total score ranges from 4 to 20. | Preoperative, and at 2 weeks (baseline), 3-, and 6-months after spine surgery | |
Secondary | Numeric rating scale for back pain | Numeric rating scale will be used to assess the pain intensity using the single-item for back, which is scored from 0 to 10, representing no pain and the worst pain, respectively. | Preoperative, and at 2 weeks (baseline), 3-, and 6-months after spine surgery | |
Secondary | Numeric rating scale for leg pain | Numeric rating scale will be used to assess the pain intensity using the single-item for leg, which is scored from 0 to 10, representing no pain and the worst pain, respectively. | Preoperative, and at 2 weeks (baseline), 3-, and 6-months after spine surgery | |
Secondary | Intensity of physical activity | A research-grade triaxial accelerometer (Actigraph GT3x) will be used to quantify time spent in different intensities of physical activity per day. | Preoperative, and at 2 weeks (baseline), 3-, and 6-months after spine surgery | |
Secondary | Physical activity volume | A research-grade triaxial accelerometer (Actigraph GT3x) will be used to quantify total number of steps per day. | Preoperative, and at 2 weeks (baseline), 3-, and 6-months after spine surgery | |
Secondary | Depressive symptoms | PROMIS Depression 4 item short form will be used to measure depressive symtpoms. Each item is measured from 1 to 5, representing low to high depressive symptoms. Total score ranges from 4 to 20. | Preoperative, and at 2 weeks (baseline), 3-, and 6-months after spine surgery | |
Secondary | Fear of movement | A 13-item Tampa Scale for Kinesiophobia will be used to measure fear of movement. It has two sub-scales (activity avoidance and fear of pain) and the total score ranges from 13 to 52 with higher scores indicating greater fear of movement. | Preoperative, and at 2 weeks (baseline), 3-, and 6-months after spine surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06290908 -
RPE-P/TLIF for Lumbar Spinal Stenosis With Instability
|
||
Withdrawn |
NCT03223701 -
Efficacy of Using Solum IV and BMC With GFC in TLIF
|
Phase 4 | |
Recruiting |
NCT03883022 -
Vancomycin Powder Combined With Autogenous Bone Graft as a Prevention for Post-operative Infection for Spine Surgery
|
N/A | |
Completed |
NCT02902380 -
The Effect of Dexmedetomidine on Neuroendocrine Stress Hormone Release and Heart Rate Variability in Patients Undergoing Major Spinal Surgery
|
N/A | |
Not yet recruiting |
NCT06024785 -
Vertebropexy - Randomized-controlled Trial
|
N/A | |
Not yet recruiting |
NCT06000319 -
Natural Matrix Protein™ (NMP™) Fibers in Cervical and Lumbar Interbody Fusion
|
||
Completed |
NCT02558621 -
New Robotic Assistance System for Spinal Fusion Surgery
|
N/A | |
Completed |
NCT02454400 -
Pre-surgery Physiotherapy for Patients With Specific Low Back Pain
|
N/A | |
Completed |
NCT01377623 -
Pilot Study on the Effect of Dexmedetomidine on Inflammatory Responses in Patients Undergoing Lumbar Spinal Fusion
|
N/A | |
Completed |
NCT00996073 -
Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion
|
Phase 2 | |
Terminated |
NCT00974623 -
Bone Graft Materials Observational Registry
|
N/A | |
Completed |
NCT00022776 -
Surgical Versus Nonsurgical Treatment for Spinal Stenosis
|
Phase 3 | |
Completed |
NCT00320619 -
Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery
|
N/A | |
Completed |
NCT06060821 -
Validity and Reliability of the 2-minute Step Test in Patients With Lumbar Spinal Stenosis
|
||
Recruiting |
NCT04552145 -
Physical Therapy vs Surgical Decompression for Lumbar Spinal Stenosis
|
N/A | |
Active, not recruiting |
NCT04379921 -
Improving Spine Surgical Care With Real-Time Objective Patient Tracking Using the Apple Watch
|
N/A | |
Withdrawn |
NCT04315090 -
Post-surgical Outcomes Measure Using the ERAS Protocol for Posterior Cervical Decompression and Fusion
|
||
Recruiting |
NCT04601363 -
Personalized Spine Study Group (PSSG) Registry
|
||
Completed |
NCT04193488 -
Mid-Transverse Process to Pleural (MTP) Block and Erector Spinal Plan (ESP) Block in Spinal Surgery
|
N/A | |
Completed |
NCT02931279 -
PASS OCT® Post-market Clinical Follow-up
|